Prothena Corp (PRTA)

$48.25 0.58 (1.19%)

16:00 EDT PRTA Stock Quote Delayed 30 Minutes

Why Is Prothena (PRTA) Stock Up 75% Today?

By William White, InvestorPlace Writer Sep 28, 2022

Prothena (PRTA) stock is seeing massive gains on Wednesday despite a lack of recent news from the late-stage clinical company.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

7 Electric Vehicle Stocks With the Most Potential for 2023 and Beyond

7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts

More Articles

Volume:

Previous Close -

Market Cap 2.17B

PE Ratio -17.67

EPS -2.73

Volume (Avg. Vol.) 303,903

Day's Range $47.95 - $49.74

52-Week Range $45.06 - $79.65

Dividend & Yield N/A (N/A)

PRTA Stock Predictions, Articles, and Prothena Corp News

From InvestorPlace
From the Web

7 A-Rated Biotechs to Buy for the Long Run

By Louis Navellier and the InvestorPlace Research Staff Dec 3, 2021

The one thing the pandemic has shown us is biotechs are changing the way we treat diseases. These A-rated biotechs are great examples.

7 A-Rated Healthcare Stocks to Buy for the Long Haul

By Louis Navellier and the InvestorPlace Research Staff Nov 1, 2021

It looks like we're on the back end of the Covid pandemic, so it's a good time to look at healthcare stocks that have a big future.

7 Healthcare Stocks That Will Cripple Your Portfolio

By Louis Navellier, Editor, Growth Investor Jan 13, 2017

Healthcare is undergoing significant transition, so avoid the weakest ones that are prone to downside risk under the incoming administration.

37 Biotechnology Stocks to Sell Now

By Portfolio Grader Dec 26, 2016

This week, the overall grades of 37 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Biggest Movers in Manufacturing Stocks Now – LEDS PXLW FATE DVAX

By Portfolio Grader Nov 22, 2016

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

32 Biotechnology Stocks to Sell Now

By Portfolio Grader Nov 21, 2016

This week, the overall grades of 32 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

52 Biotechnology Stocks to Sell Now

By Portfolio Grader Nov 14, 2016

The overall ratings of 52 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Biggest Movers in Manufacturing Stocks Now – XLRN KPTI SODA PRTA

By Portfolio Grader Nov 10, 2016

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

32 Biotechnology Stocks to Sell Now

By Portfolio Grader Sep 5, 2016

The ratings of 32 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

10 Biotechnology Stocks to Sell Now

By Portfolio Grader Aug 1, 2016

This week, 10 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Hottest Manufacturing Stocks Now – LIFE AFMD IMMU DMTX

By Portfolio Grader Jul 20, 2016

The following stocks were moving the Manufacturing sector today.

Hottest Manufacturing Stocks Now – SPU AGLE CPHR OCRX

By Portfolio Grader Jul 13, 2016

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

Biggest Movers in Manufacturing Stocks Now – ADAP AQXP RGLS AEZS

By Portfolio Grader Jul 4, 2016

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

Biggest Movers in Manufacturing Stocks Now – HOG QBAK DRNA ASMB

By Portfolio Grader Jul 1, 2016

The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

Hottest Manufacturing Stocks Now – LINK SBOT AGLE TGEN

By Portfolio Grader Jun 24, 2016

The following stocks were moving the Manufacturing sector today.

3 Biotech Stocks at Risk From the 2016 U.S. Presidential Election (ANIP ARIA PRTA)

By Profit Scanner Jun 23, 2016

As the 2016 election nears, a possible Clinton presidency weighs on Big Pharma. Profit Scanner identified three biotech stocks in particular.

Prothena GAAP EPS of -$1.03 misses by $0.06, revenue of $4M misses by $0.52M (NASDAQ:PRTA)

From Seeking Alpha Aug 3, 2023

Prothena press release (PRTA): Q2 GAAP EPS of -$1.03 misses by $0.06.Revenue of $4M (+207.7% Y/Y) misses by $0.52M.Revised year-end cash guidance to be approximately $600 million...

Prothena stock adds ex-FDA neuro chief Billy Dunn to board (NASDAQ:PRTA)

From Seeking Alpha May 17, 2023

Alzheimer's drug developer Prothena (PRTA) announced Tuesday that Billy Dunn, who previously led the FDA's Office of Neuroscience, is joining its board. Read more here.

Lilly stock sends Alzheimer’s drug developers higher after trial data

From Seeking Alpha May 3, 2023

Eli Lilly (LLY) added ~7% after the company reported early Phase 3 data for its Alzheimer's drug donanemab sparking sharp gains among rivals. Read full story here.

(NASDAQ:PRTA)

From Seeking Alpha Feb 23, 2023

Prothena press release (PRTA): Q4 GAAP EPS of $0.12 beats by $0.61.Revenue of $49.9M (vs

H.C. Wainwright Sticks to Its Buy Rating for Prothena (PRTA)

From TipRanks Nov 15, 2022

In a report released today, Andrew Fein from H.C. Wainwright maintained a Buy rating on Prothena (PRTA – Research Report), with a price target of $75.00. The ...

Prothena (PRTA) Receives a Buy from JMP Securities

From TipRanks Nov 14, 2022

JMP Securities analyst Jason Butler reiterated a Buy rating on Prothena (PRTA – Research Report) today and set a price target of $82.00. The company’s s...